Search Results 531-540 of 17339 for globulin
Mayo Clinic researchers are examining the effectiveness of a variety of precautions taken to reduce the risk of hemophiliac hemorrhage during surgeries. Mayo ...
All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...
There's still time! ... Hurry to 3X your gift's impact on cancer research and care! Triple My Impact.
Hodgkin's lymphoma · Lymphoma · Non-Hodgkin's lymphoma · Cutaneous T-cell lymphoma; Castleman disease. Request an appointment. Aug. 30, 2025. Print.
Learn about the symptoms, diagnosis and treatment for this deadly form of cancer.
This rare disease caused by a buildup of the protein amyloid can affect different organs in different people. Find out how early and accurate diagnosis can ...
Your treatment team may include specialists in blood (hematologists), connective tissue and arthritis (rheumatologists), liver diseases (hepatologists), the ...
Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms. Blood Cancer J. 2022 Feb 01; 12(2):25 ...
The purpose of this study is to evaluate safety and tolerability of multi-kinase inhibitor LNK01002 in patients with primary myelofibrosis (MF), or MF due to ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.